1. Executive Summary
2. Research Methodology
3. Vascular Stents
3.1 Background
3.2 Overview
3.3 Classification
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market share by Type
4.2.3 Market Share by Region
5. Market Segmentation
5.1 Coronary Stents
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.1.3 Market Share by Products
5.1.3.1 Bare Metal Stent
5.1.3.2 Bioresorbable Stent
5.1.3.3 Drug Eluting Stent
5.1.4 Market Share by Region
5.2 Neurovascular Stents
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.3 Peripheral Vascular Stents
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
5.3.3 Market Share by Products
5.3.3.1 Femoral Artery Stent
5.3.3.2 Infrapop Artery Stent
5.3.3.3 Iliac Artery Stent
5.3.5 Market Share by Region
6. Regional Analysis
6.1 North America
6.1.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.1.2 Market Share by Stent Type
6.1.3 The US
6.1.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2 Europe
6.2.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Stent Type
6.3 Asia Pacific
6.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Products
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Advent of Bioresorbable Vascular Stents
7.1.2 Technological Advancement
7.2 Growth Drivers
7.2.1 Increasing Geriatric Population
7.2.2 Prevalence of Vascular Diseases
7.2.3 Preference for Minimally Invasive Procedures
7.2.4 Favorable Reimbursement Policies
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 Post-Operative Complications
7.3.3 Slow Adoption Rate
7.3.4 High Cost of Devices
8. Competitive Landscape
8.1 Market Share Analysis
9. Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic PLC
9.3 Boston Scientific Corporation
9.4 Microport Scientific Corporation